Basics Viridian Therapeutics, Inc. IPO Date: June 16, 2014 Sector: Healthcare Industry: Biotech Market Cap: $3.06B Activated in VL: True Average Daily Range Avg Daily Range: $0.51 | 2.78% Avg Daily Range (30 D): $0.50 | 1.81% Avg Daily Range (90 D): $0.49 | 2.24% Institutional Daily Volume Avg Daily Volume: .56M Avg Daily Volume (30 D): 1.49M Avg Daily Volume (90 D): 1.03M Trade Size Avg Trade Size (Sh.): 67 Avg Trade Size (Sh.) (30 D): 68 Avg Trade Size (Sh.) (90 D): 65 Institutional Trades Total Inst.Trades: 1,866 Avg Inst. Trade: $1.99M Avg Inst. Trade (30 D): $2.44M Avg Inst. Trade (90 D): $2.32M Avg Inst. Trade Volume: .1M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $2.7M Avg Closing Trade (30 D): $4.6M Avg Closing Trade (90 D): $3.19M Avg Closing Volume: 141.84K     News Nov 17, 2025 @ 11:00 AM 4DMT Appoints Kristian Humer as Chief Financial Of... Source: 4D Molecular Therapeutics Oct 16, 2025 @ 5:00 PM Thyroid Eye Disease Clinical Trial Pipeline Gains ... Source: Delveinsight Sep 29, 2025 @ 5:35 PM 10 Health Care Stocks With Whale Alerts In Today's... Source: Benzinga Staff Writer Aug 6, 2025 @ 4:28 PM Viridian (VRDN) Q2 Net Loss Widens 55% Source: Jesterai Oct 15, 2024 @ 3:45 PM Ophthalmic Disease Therapeutics Market Analysis by... Source: Researchandmarkets.Com Financials   TTM Q2 2025 Q1 2025 Basic EPS Diluted EPS Revenue $ 70.57M $ .08M $ .07M Gross Profit $ $ $ Net Income / Loss $ -34.6M $ -100.74M $ -86.91M Operating Income / Loss $ -40.01M $ -106.77M $ -93.87M Cost of Revenue $ $ $ Net Cash Flow $ 52.32M $ 1.11M $ 16.62M PE Ratio     Splits Nov 13, 2020:   1:15 Nov 07, 2016:   1:15